Status:
COMPLETED
Diclofenac vs. Ropivacaine for Cesarean Section
Lead Sponsor:
Meir Medical Center
Conditions:
Cesarean Section
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
A prospective, randomized, double blind study designed to investigate analgesic efficacy of wound infusion using diclofenac or ropivacaine following Cesarean section performed via a Pfannenstiel incis...
Detailed Description
Study Objective: To assess the analgesic efficacy of diclofenac or ropivacaine when administered via wound infusion. Design: Prospective, randomized, double-blind, placebo-controlled study. Setting: ...
Eligibility Criteria
Inclusion
- Patients undergoing Cesarean section
Exclusion
- A history of clinically significant disease:
- cardiovascular
- pulmonary
- hepatic
- renal
- neurologic
- psychiatric
- metabolic disease
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00801528
Start Date
April 1 2008
End Date
December 1 2008
Last Update
May 4 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel, 44281